Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy
Conditions: Chemotherapy Induced Systolic Dysfunction Interventions: Drug: Carvedilol; Drug: Ramipril; Drug: Rosuvastatin; Drug: Colchicine; Drug: Placebo Sponsors: Arab Contractors Medical Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
Conditions: T2DM (Type 2 Diabetes Mellitus); Dyslipidemias Interventions: Drug: Statin and Ezefeno; Drug: Statin doubling Sponsors: Korea University Anam Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials

Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)
Conditions: Coronary Artery Disease; Atherosclerosis, Coronary Interventions: Drug: Statin; Drug: Aspirin tablet; Drug: Nexlizet; Drug: LEQVIO; Drug: Vascepa; Drug: Jardiance; Drug: Colchicine Sponsors: University of Louisville Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain)
Conditions: Alzheimer Disease Interventions: Diagnostic Test: Kit Buccal swab collection& stabilization de Canvax ®; Other: Cholesterol levels according to ApoE Genotype; Other: Assessing cardiovascular risk factors in all participants Sponsors: Universidad de Le ón; Consejo General de Colegios Oficiales de Enfermería España Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

Specified Drug-use Survey of Leqvio for s.c. Injection.
Conditions: Familial Hypercholesterolaemia; Hypercholesterolaemia Interventions: Other: inclisiran Sponsors: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
Conditions: Cardiovascular Diseases; Dyslipidemias; Statin Adverse Reaction; Pharmacogenic Myopathy Interventions: Other: Preemptive pharmacogenetic atorvastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic simvastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic pitavastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic rosuvastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic pravastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic lovastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic fluvastatin dose ...
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials

Statin Addition to Chemotherapy for Advanced Pancreatic Cancer
Conditions: Advanced Pancreatic Cancer Interventions: Drug: statin addition to chemotherapy Sponsors: Changhai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials

A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Conditions: Hyperlipidemias Interventions: Drug: SGB-3403; Other: Atorvastatin; Other: Placebo Sponsors: Suzhou Sanegene Bio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials

Community Intervention to Improve CVD Risk Factor Control in Young American Indians
Conditions: Cholesterol, Elevated; Diabetes Mellitus Interventions: Other: Guided management Sponsors: University of Oklahoma; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials

BVA-200 vs BVA-100 Validation Study
Conditions: Heart Failure; High Blood Pressure; High Cholesterol; Anemia; Diabetes; Thyroid Diseases; Kidney Diseases; Clotting Disorder; Trauma; Other Disease Interventions: Diagnostic Test: BVA-200 Sponsors: Daxor Corporation; Stern Cardiovascular Foundation, Inc.; Oregon Health and Science University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials

Cardioprotective and Mental Health Benefits of the MIND Diet Combined With Forest Bathing
Conditions: Elevated LDL Cholesterol Interventions: Other: Mind diet intervention; Other: Mind plus FB intervention; Other: Usual care Sponsors: Tung Wah College Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials

LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study
Conditions: LCAT Deficiency Interventions: Other: Demographics, diagnosis type, genotype, lipid profile, renal function profile, treatment allocation, ophthalmology exam, country of residence. Sponsors: University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

Topical Statin Eye Drop in the Management of the Dry Eye
Conditions: Dry Eye Disease Interventions: Drug: Statin eye drop; Drug: Placebo Sponsors: Shahid Beheshti University of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials

InterVFast —effectiveness and acceptance of intermittent fasting in cardiac rehabilitation patients: study protocol of a randomized controlled trial
DiscussionCompared to other weight-loss intervention studies, our study addresses patients with coronary heart disease and includes patients ’ acceptance as well as long-term maintenance. It is hypothesized that participation in the InterVfast intervention will improve relevant health outcomes in a sample of cardiac rehabilitation patients and thus constitute a behavioural prevention strategy to reduce the risk of future cardiac events and improve overall health and quality of life.Trial registrationClinicalTrials.gov DRKS00023983. Registered on February 17, 2022. (Source: Trials)
Source: Trials - January 9, 2024 Category: Research Source Type: clinical trials

A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)
Conditions: Healthy Volunteers Interventions: Drug: Atorvastatin; Drug: ALG-055009; Drug: Rosuvastatin Sponsors: Aligos Therapeutics Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials